Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07947498
NA

Prognostic Value of 2-Week ECG Monitoring After PCI in Acute Myocardial Infarction

Sponsor: Chungnam National University Hospital

View on ClinicalTrials.gov

Summary

This single-center, single-group study will evaluate the prognostic value of long-term electrocardiographic monitoring in adults with acute myocardial infarction who undergo primary percutaneous coronary intervention. After written informed consent, eligible participants will have a MEMO Patch2 long-term Holter monitor applied on the day of, or the day after, the procedure and will wear it for 2 weeks. The study will classify high-risk arrhythmias detected during monitoring and compare long-term clinical outcomes according to arrhythmia classification.

Official title: Evaluation of the Prognostic Value of Long-term(2 Weeks) Electrocardiogram Analysis After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2024-08-02

Completion Date

2026-12-31

Last Updated

2026-11-19

Healthy Volunteers

No

Interventions

DEVICE

MEMO Patch2

MEMO Patch2 is a detachable long-term Holter monitoring device. It will be applied on the day of, or the day after, primary percutaneous coronary intervention and worn for 2 weeks to record arrhythmias that may be missed by in-hospital monitoring. It will be removed at an outpatient visit, and the recordings will then be analyzed.

Locations (1)

Chungnam National University Hospital

Daejeon, South Korea